|1.||Andrews, Paul L R: 4 articles (01/2014 - 02/2010)|
|2.||Sanger, Gareth J: 2 articles (01/2014 - 09/2013)|
|3.||Doyle, Mary: 2 articles (01/2014 - 01/2010)|
|4.||Dowswell, Therese: 2 articles (01/2014 - 01/2010)|
|5.||Matthews, Anne: 2 articles (01/2014 - 01/2010)|
|6.||Haas, David M: 2 articles (01/2014 - 01/2010)|
|7.||Horn, Charles C: 2 articles (01/2013 - 03/2007)|
|8.||Rudd, John A: 2 articles (02/2010 - 08/2006)|
|9.||Waddell, Aubrey: 1 article (02/2016)|
|10.||Daniel, Divya: 1 article (02/2016)|
09/05/2013 - "The mechanisms and treatments are unclear (anti-emetic drugs are not fully effective against nausea). "
01/01/2015 - "This review summarises the current knowledge of nausea mechanisms, the available animal models for nausea research and the anti-nausea properties of commercially available anti-emetic drugs. "
03/30/2007 - "The acute effects of these treatments are partly controlled using anti-emetic drugs, but the delayed effects (>24 h), especially nausea, are much more difficult to treat. "
06/30/2006 - "This model could be useful for studying both the mechanisms leading to nausea associated with a long-term antineoplastic treatment and the efficiency of new anti-emetic drugs."
06/01/1997 - "The central objectives of this study were to evaluate the cognitive, psychomotor and subjective effects of two anti-emetic drugs of established value in the prophylaxis of radiation induced nausea and vomiting. "
03/01/2009 - "We also note several factors that indicate that there are additional problems in the use of time to emesis for triage, including a lack of consideration of individuals that do not vomit, differences between the conditions under which the data were obtained and the conditions under which they are likely to be used, and the potential for the incidence of vomiting to be altered by factors unrelated to radiation exposure such as psychogenic factors and the use of emetic agents. "
04/01/2004 - "5-Hydroxytrypamine(3) (5-HT(3)) receptor antagonists, when used alone, are unsatisfactory in the attenuation of emesis; Furthermore, consensus about their optimal dose, optimal dosing frequency and the combined use with other anti-emetic drugs are still controversial. "
05/01/1999 - "YG character test in 23 cases revealed that emotional unstableness, characterized by the coupled rightward shift of the N (nervous) and I (inferior complex) components, was the important cause of emesis in those patients who failed to respond to the anti-emetic drugs shown above. "
09/01/1997 - "On average, the children experienced loss of appetite on 50% of the days, vomiting on 12%, and received anti-emetic drugs on 38%. "
09/01/1997 - "The number of days with loss of appetite, vomiting, and the number of days on anti-emetic drugs were also recorded. "
|3.||Postoperative Nausea and Vomiting (PONV)
07/01/1999 - "Effective treatment for postoperative nausea and vomiting continues to be elusive, despite the introduction of new anti-emetic drugs. "
11/01/2011 - "Although most surveyed practitioners were well informed about the new guidelines concerning PONV prevention, 27% not follow these guidelines regarding the administration of anti-emetic drugs. "
09/01/2008 - "A correlation between those factors and prophylactic anti-emetic drugs, as well as between their use and the development of PONV, was not observed. "
11/01/2004 - "Although site of surgery and previous occurrence of postoperative nausea and vomiting are often used to decide whether prophylactic anti-emetic drugs are indicated, the value of these predictors is unclear. "
03/01/2001 - "A management strategy for PONV in the recovery room involving continued use of present anaesthetic agents, increased use of inexpensive anti-emetic drugs currently available in Guyana, and targeting of patients found to be more at risk is suggested. "
12/01/2012 - "With the increase use of anti-emetic drugs in cancer chemotherapy, we have to be aware of this possible visual complication."
08/01/1985 - "The emetics, apomorphine and the cancer chemotherapeutic drug cyclophosphamide, were given IP immediately after the conditioning trial at doses that induced taste aversions. "
12/01/2007 - "Updated anti-emetic guidelines were published in 2007 by the National Comprehensive Cancer Network and in 2006 by the American Society of Clinical Oncology, which have included the use of the new and more effective anti-emetic agents (5-hydroxytryptamine-3 [5-HT(3)] receptor antagonists and neurokinin-1 [NK-1] receptor antagonists). "
09/01/1981 - "At present phenothiazines are the only class of antiemetics that have shown both efficacy and safety in large numbers of cancer patients, but they are inadequate against strongly emetic agents such as cisplatin. "
10/01/1992 - "In a phase II study including 80 patients treated with highly emetic drugs such as cisplatin, carboplatin or cyclophosphamide > 600 mg/day) we confirmed the potential of ondansetron to prevent cancer chemotherapy- related acute nausea and vomiting. "
10/05/2015 - "In this study, we investigated the characteristics of teriparatide-induced pica and the abilities of anti-emetic drugs to inhibit teriparatide-induced pica. "
07/01/2011 - "It is known that pica, the consumption of non-nutritive substances such as kaolin, can be induced by administration of toxins or emetic agents in rats. "
06/30/2006 - "Furthermore, pica, measured as kaolin intake, is reduced by anti-emetic drugs. "
12/01/2014 - "We tested this hypothesis by measuring the pica behavior (kaolin clay intake) of rats, because it is known that rats engage in pica behavior after various nausea-inducing treatments including irradiation, motion sickness, and injection of emetic drugs such as lithium chloride (LiCl). "
|1.||Morphine (MS Contin)
|4.||Vitamin B 6
|8.||Serotonin (5 Hydroxytryptamine)
|1.||Drug Therapy (Chemotherapy)
|3.||First Aid (Aids, First)
|4.||Vagus Nerve Stimulation
|5.||Intensive Care (Surgical Intensive Care)